1-3 of 3
thalidomide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study

Clinical Trials & Observations
Xiao-Qi Qin, Gang An, Zeng-Jun Li, Lan-Ting Liu, Yan Xu, Lin-Hua Yang, Yan-Ping Ma, Shu-Hui Deng, Wei-Wei Sui, Yu Qin, Xiao-Yan Feng, Mei-Rong Zang, Wen-Juan Yang, Yan-Ru Zhang, Shu-Hua Yi, Ting-Yu Wang, Rui Lv, De-Hui Zou, Yao-Zhong Zhao, Lu-Gui Qiu
Journal: Blood Advances
Blood Adv (2019) 3 (5): 751–760.
https://doi.org/10.1182/bloodadvances.2018019851
Published: 2019
Journal Articles

Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Maximilian Merz, Anna Jauch, Thomas Hielscher, Tilmann Bochtler, Stefan Olaf Schönland, Anja Seckinger, Dirk Hose, Uta Bertsch, Kai Neben, Marc Steffen Raab, Jens Hillengass, Hans Salwender, Igor Wolfgang Blau, Hans-Walter Lindemann, Ingo G. H. Schmidt-Wolf, Christof Scheid, Mathias Haenel, Katja C. Weisel, Hartmut Goldschmidt
Journal: Blood Advances
Blood Adv (2017) 2 (1): 1–9.
https://doi.org/10.1182/bloodadvances.2017013334
Published: 2017
Includes: Supplemental data
Journal Articles

Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States

Clinical Trials & Observations
Luciano J. Costa, Ilene K. Brill, James Omel, Kelly Godby, Shaji K. Kumar, Elizabeth E. Brown
Journal: Blood Advances
Blood Adv (2017) 1 (4): 282–287.
https://doi.org/10.1182/bloodadvances.2016002493
Published: 2017
Includes: Supplemental data